Page last updated: 2024-08-23

idarubicin and trofosfamide

idarubicin has been researched along with trofosfamide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J1
Asea, A; Boos, J; Borkhardt, A; Dantonello, T; Hoehn, T; Klee, D; Koscielniak, E; Krefeld, B; Siepermann, M; Wessalowski, R1

Trials

1 trial(s) available for idarubicin and trofosfamide

ArticleYear
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine

2008

Other Studies

2 other study(ies) available for idarubicin and trofosfamide

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy.
    Pediatric blood & cancer, 2012, Volume: 58, Issue:1

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Idarubicin; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Rhabdomyosarcoma, Alveolar

2012